![](/images/ico/ico_close.png)
![](/images/ico/ico3.png)
Period of time: 2014年3期
Publisher: Informa Healthcare
Founded in: 2002
Total resources: 54
ISSN: 1474-0338
Subject: R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Safety,volume 12,issue 3
Menu
![](/images/ico/ico5.png)
Statin use and the risk of esophageal cancer: a population-based case-control study
Expert Opinion on Drug Safety,volume 12,issue 3 , Vol. 12, Iss. 3, 2013-05 , pp.![](/images/ico/ico5.png)
![](/images/ico/ico5.png)
![](/images/ico/ico5.png)
Sertindole: dilemmas for its use in clinical practice
Expert Opinion on Drug Safety,volume 12,issue 3 , Vol. 12, Iss. 3, 2013-05 , pp.![](/images/ico/ico5.png)
The controversy of a wider statin utilization: why?
Expert Opinion on Drug Safety,volume 12,issue 3 , Vol. 12, Iss. 3, 2013-05 , pp.![](/images/ico/ico5.png)
Clinical and causality assessment in herbal hepatotoxicity
Expert Opinion on Drug Safety,volume 12,issue 3 , Vol. 12, Iss. 3, 2013-05 , pp.![](/images/ico/ico5.png)
Lenalidomide and thalidomide in the treatment of chronic pain
By Asher Christopher,Furnish Timothy in (2013)
Expert Opinion on Drug Safety,volume 12,issue 3 , Vol. 12, Iss. 3, 2013-05 , pp.![](/images/ico/ico5.png)
Testosterone exposure in childhood: discerning pathology from physiology
By Cabrera Susanne M in (2013)
Expert Opinion on Drug Safety,volume 12,issue 3 , Vol. 12, Iss. 3, 2013-05 , pp.![](/images/ico/ico5.png)
Oxycodone combined with opioid receptor antagonists: efficacy and safety
By Davis Mellar,Goforth Harold W,Gamier Pam in (2013)
Expert Opinion on Drug Safety,volume 12,issue 3 , Vol. 12, Iss. 3, 2013-05 , pp.![](/images/ico/ico5.png)
Interactions between oral antineoplastic agents and concomitant medication: a systematic review
By Carcelero Esther,Anglada Helena,Tuset Montse,Creus Natalia in (2013)
Expert Opinion on Drug Safety,volume 12,issue 3 , Vol. 12, Iss. 3, 2013-05 , pp.